Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
15.85
+1.59 (11.15%)
Jan 17, 2025, 4:00 PM EST - Market closed
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vicarious Surgical stock have an average target of 10.25, with a low estimate of 10 and a high estimate of 10.5. The average target predicts a decrease of -35.33% from the current stock price of 15.85.
Analyst Consensus: Hold
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for RBOT stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | -33.75% | Nov 13, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | -24.29% | Aug 13, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | -36.91% | Jul 15, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $45 → $30 | Hold | Maintains | $45 → $30 | +89.27% | Mar 5, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $18 | Hold | Initiates | $18 | +13.56% | Dec 4, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-11.14
from -14.70
EPS Next Year
-9.72
from -11.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -11.26 | -7.43 | -5.15 | |
Avg | -11.14 | -9.72 | -7.35 | |
Low | -10.91 | -11.35 | -11.06 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.